Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

Detalles Bibliográficos
Autores principales: Ratner, L, Rauch, D, Abel, H, Caruso, B, Noy, A, Barta, S K, Parekh, S, Ramos, J C, Ambinder, R, Phillips, A, Harding, J, Baydoun, H H, Cheng, X, Jacobson, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817103/
https://www.ncbi.nlm.nih.gov/pubmed/27015285
http://dx.doi.org/10.1038/bcj.2016.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817103/
https://www.ncbi.nlm.nih.gov/pubmed/27015285
http://dx.doi.org/10.1038/bcj.2016.21

Ejemplares similares